# Critique: finding-2

- Target Side: side_a
- Target Claim IDs: side_a-claim-1, side_a-claim-2
- Attack Type: evidence_gap
- Severity: high

## Claim Under Attack
A staged pricing experiment is the strongest recommendation under partial market data because it creates decision-quality evidence while limiting downside risk, and a full immediate repricing should be avoided because available information does not support it.

## Evidence Or Reason
The artifact asserts that partial data is sufficient for a staged test but insufficient for a full repricing, yet provides no framework for distinguishing between these two confidence thresholds. What specific evidence quality or quantity would upgrade the recommendation from 'test' to 'commit'? Without defining this boundary, the staged-test recommendation becomes unfalsifiable: it is always the safe default regardless of how much data actually exists. The artifact also cites no evidence about the cost of delay — a prolonged test phase under competitive pressure or margin erosion could itself be an irreversible mistake if competitors reprice first or if the current price is materially below willingness-to-pay. The asymmetry claim ('overpricing damages faster than underpricing suppresses upside') is stated as a general truth without any evidence specific to this market context, and it conveniently supports the conservative recommendation without considering scenarios where underpricing signals low value, attracts wrong-fit customers, or creates anchoring that makes future increases harder.

